Programmable Drug Delivery
Turning Oral Films
into Programmable
Therapeutic Platform
September 2025
Programmable Drug Delivery
Turning Oral Films
into Programmable
Therapeutic Platform
September 2025
The ODF* Breakthrough
Thin oral drug delivery films that release Active Pharmaceutical Ingredients (APIs) upon dissolving in the mouth
Fast-Acting Impact
Direct absorption through the oral mucosa for rapid therapeutic effects
Precise Dosing
Enhanced stability and lower dosage needs through controlled delivery
Bypasses First-Pass Metabolism
Fewer systemic side effects by avoiding liver metabolism
Safety & Compliance
Fewer systemic side effects by avoiding liver metabolism
Patient-Friendly
Ideal for pediatric, geriatric, and dysphagic populations
Portable & Convenient
Discreet use, no water required – perfect for on-the-go medication
*ODF: , offering a fast, convenient, and patient-friendly alternative to traditional tablets or liquids.
The ODF* Breakthrough
The ODF* Breakthrough
Thin oral drug delivery films that release Active Pharmaceutical Ingredients (APIs) upon dissolving in the mouth
Fast-Acting Impact
Direct absorption through the oral mucosa for rapid therapeutic effects
Precise Dosing
Enhanced stability and lower dosage needs through controlled delivery
Bypasses First-Pass Metabolism
Fewer systemic side effects by avoiding liver metabolism
Safety & Compliance
Fewer systemic side effects by avoiding liver metabolism
Patient-Friendly
Ideal for pediatric, geriatric, and dysphagic populations
Portable & Convenient
Discreet use, no water required – perfect for on-the-go medication
*ODF: Oral Drug Films
ODF Revolution Lingered Due to Tech Constraints
Narrow Therapeutic Impact
Restricted APIs capacity per strip (<50 mg)
Limited Release Control
Short absorption window (few minutes)
Limited API Flexibility
Poor handling of conflicting active ingredients
High Manufacturing Complexity & Cost
solvent-casting processes dominate
ODF Revolution Lingered Due to Tech Constraints
ODF
Those constraints have prevented ODF solutions from offering a much wider set of efficient applications
Narrow Therapeutic Impact
Restricted APIs capacity per strip (<50 mg)
Limited Release Control
Short absorption window (few minutes)
Limited API Flexibility
Poor handling of conflicting active ingredients
High Manufacturing Complexity & Cost
solvent-casting processes dominate
Introducing P-ODF
The first Programmable Platform,
Disrupting Drug Delivery
Dosage Quantities
Up to (exceptional) 150mg
Full Release Control
Flexible Time Patterns,
minutes to 12 hours
Multi API Mix
Introducing conflicting materials
Flexible Manufacturing Process
Allows small and large tailored batches per need
Introducing
P-ODF
The first Programmable Platform,
Disrupting Drug Delivery
Dosage Quantities
Up to (exceptional) 150mg
Full Release Control
Flexible Time Patterns,
minutes to 12 hours
Multi API Mix
Introducing conflicting materials
Flexible Manufacturing Process
Allows small and large tailored batches per need
Novel Enabling Technologies
P-ODF uses a proprietary biological and chemical programming mechanism with breakthrough architectural designs that enable unprecedented control over drug delivery.
Swelling Patch Technology
Hygroscopic polymer swells with humidity exposure, forming a gel for controlled, sustained API release over extended periods.
Multilayer 3D Patch
Micro-Reservoirs (Wells)
Flexible & Cost-Effective Manufacturing
Contact Us
PharMedica welcomes your comments, questions and inquiries.
Pharmedica LTD.
3 Pinchas Sapir Street
Science Park
Ness Ziona 7403626
Israel